These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5083256)

  • 1. [The protease-inhibitor capacity of human bronchial mucus. Content in low molecular inhibitor and 1 -antitrypsin under physiological and physiopathological conditions].
    Reichert R; Hochstrasser K; Conradi G
    Pneumonologie; 1972; 147(1):13-20. PubMed ID: 5083256
    [No Abstract]   [Full Text] [Related]  

  • 2. [Concentration of low-molecular protease inhibitor in the bronchial secretion in 1 -antitrypsin deficiency].
    Reichert R; Hochstrasser K; Fruhmann G; Fritz H; Werle E
    Pneumonologie; 1972; 147(1):41-5. PubMed ID: 5083260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mucous membrane specific protease inhibitors in bronchial mucus in severe chronic obstructive bronchitis and in alpha 1-antitrypsin deficiency syndrome].
    Rasche B; Hochstrasser K; Marcic I; Ulmer WT
    Respiration; 1975; 32(5):340-54. PubMed ID: 1080869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection.
    Stockley RA; Burnett D
    Bull Eur Physiopathol Respir; 1980; 16 Suppl():261-72. PubMed ID: 6164421
    [No Abstract]   [Full Text] [Related]  

  • 5. Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum.
    Ohlsson K; Tegner H
    Eur J Clin Invest; 1975 Jun; 5(3):221-7. PubMed ID: 50236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inter-alpha-trypsin inhibitor in serum and bronchial mucus inhibitor in sputum in chronic airway obstruction (author's transl)].
    Rasche B; Hochstrasser K; Ulmer WT
    Respiration; 1978; 36(1):39-47. PubMed ID: 307266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in protease inhibitor balance of the bronchoalveolar secretion in children with inflammatory lung diseases].
    Bogadel'nikov IV; Kubyshkin AV; Gavalova NG
    Pediatriia; 1990; (3):17-20. PubMed ID: 2385464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increase in sensitivity of the bronchial muscles by means of proteolytic enzymes in sputum].
    Islam MS; Rasche B; Vastag E; Ulmer WT
    Pneumonologie; 1971; 146(3):232-40. PubMed ID: 5158612
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor.
    Ohlsson K; Tegner H
    Scand J Clin Lab Invest; 1976 Sep; 36(5):437-45. PubMed ID: 185683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitrypsin deficiency and abnormal protease inhibitor phenotypes.
    Mittman C; Barbela T; Lieberman J
    Arch Environ Health; 1973 Sep; 27(3):201-6. PubMed ID: 4198687
    [No Abstract]   [Full Text] [Related]  

  • 11. The interactions between a low molecular weight protease inhibitor of bronchial mucus and chymotrypsin-like cationic proteins of granulocytes.
    Tegner H; Ohlsson K; Olsson I
    Hoppe Seylers Z Physiol Chem; 1977 Apr; 358(4):431-3. PubMed ID: 863383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of corticosteroids on sputum sol-phase protease inhibitors in chronic obstructive pulmonary disease.
    Wiggins J; Elliott JA; Stevenson RD; Stockley RA
    Thorax; 1982 Sep; 37(9):652-6. PubMed ID: 6984237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibitors of proteases in bronchial secretion of patients deficient in alpha-l-antitrypsin].
    Laine A; Lebas J; Hayem A
    Lille Med; 1976 Feb; 21(2):140-3. PubMed ID: 1084948
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of serum alpha 1-antitrypsin on the proteolytic activity of purulent sputum].
    Tarján E; Tolnay P
    Orv Hetil; 1974 Jan; 115(2):78-80. PubMed ID: 4839163
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a bronchial inhibitor in the sputum of chronic bronchitics.
    Girard F; Tournier JM; Polu JM; Sadoul P
    Bull Eur Physiopathol Respir; 1980; 16 Suppl():237-45. PubMed ID: 6971671
    [No Abstract]   [Full Text] [Related]  

  • 16. Elastase inhibitors of sputum sol phase: variability, relationship to neutrophil elastase inhibition, and effect of corticosteroid treatment.
    Stockley RA; Morrison HM; Kramps JA; Dijkman JH; Burnett D
    Thorax; 1986 Jun; 41(6):442-7. PubMed ID: 2431494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elastase inhibitors in sputum from bronchitic patients with and without alpha 1-proteinase inhibitor deficiency: partial characterization of a hitherto unquantified inhibitor of neutrophil elastase.
    Morrison HM; Kramps JA; Afford SC; Burnett D; Dijkman JH; Stockley RA
    Clin Sci (Lond); 1987 Jul; 73(1):19-28. PubMed ID: 2440636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions among stimulated human polymorphonuclear leucocytes, released elastase and bronchial antileucoprotease.
    Kramps JA; van Twisk C; Klasen EC; Dijkman JH
    Clin Sci (Lond); 1988 Jul; 75(1):53-62. PubMed ID: 2842104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Free and combined protease inhibitors in bronchial mucus in patients with extended chronic obstructive airway diseases (author's transl)].
    Hochstrasser K; Rasche B; Reichert R; Hochgesand K
    Pneumonologie; 1974; 150(2-4):253-9. PubMed ID: 4419015
    [No Abstract]   [Full Text] [Related]  

  • 20. Low molecular mass bronchial proteinase inhibitor and alpha 1-proteinase inhibitor in sputum and bronchoalveolar lavage.
    Stockley RA; Morrison HM; Smith S; Tetley T
    Hoppe Seylers Z Physiol Chem; 1984 May; 365(5):587-95. PubMed ID: 6332053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.